Climara combined with Estrace

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Progesterone Receptor Assay Positive Other Serious 1/14/2002 54 Female 1/31/2006 Consumer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 2/1/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/25/2002 Female 2/28/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/25/2002 Female 3/1/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/2/2001 64 Female 4/11/2006 Lawyer United States
Primary
Secondary
Weight Increased Hospitalization 10/13/1998 56 Female 172 lb 4/5/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/1/2001 Female 2/8/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/2/2001 64 Female 4/12/2006 United States
Primary
Secondary
Neoplasm Malignant Other Serious 12/14/1995 54 Female 190 lb 4/18/2006 Physician United States
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 4/21/2006 Physician United States
Primary
Secondary
Concomitant
Weight Increased Other Serious 60 Female 180 lb 5/31/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/1/2001 Female 6/8/2006 Consumer United States
Primary
Secondary
Ovarian Cancer Other Serious 1/1/2003 Female 161 lb 6/8/2006 Consumer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 6/1/2006 Physician United States
Primary
Secondary
Concomitant
Ovarian Cancer Other Serious Female 7/12/2006 Consumer United States
Primary
Secondary
Ovarian Cancer Metastatic Other Serious 8/1/2002 59 Female 162 lb 7/12/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Required Intervention Female 6/15/2006 Lawyer United States
Primary
Secondary
Ovarian Cancer Metastatic Other Serious 8/1/2002 59 Female 162 lb 7/26/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 6/2/2001 64 Female 7/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Required Intervention 1/14/2002 54 Female 145 lb 7/7/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 8/1/2004 53 Female 9/5/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 8/1/2004 53 Female 9/5/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/2/2001 Female 156 lb 12/30/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2004 53 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/25/2002 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2001 51 Female 140 lb 10/10/2006 United States
Primary
Secondary
Injury Other Serious 10/1/2001 Female 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 8/27/2002 67 Female 2/7/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2001 Female 165 lb 2/22/2007 United States
Primary
Secondary
Concomitant
Mastectomy Other Serious 1/25/2002 Female 11/3/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2001 54 Female 12/22/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/25/2002 Female 1/31/2007 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 8/1/2004 53 Female 2/7/2007 Consumer United States
Primary
Secondary
Breast Cancer In Situ Other Serious 12/27/2001 56 Female 138 lb 2/7/2007 Physician United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/2000 59 Female 156 lb 2/7/2007 Lawyer United States
Primary
Secondary
Irritable Bowel Syndrome Other Serious 7/7/1998 65 Female 185 lb 2/7/2007 Physician United States
Primary
Secondary
Concomitant
Ovarian Cancer Other Serious Female 2/7/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2004 51 Female 130 lb 6/12/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Rectal Polypectomy Other Serious 1/1/1997 53 Female 105 lb 6/26/2007 United States
Primary
Secondary
Breast Cancer Required Intervention 1/14/2002 54 Female 145 lb 7/5/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 1/27/2001 54 Female 212 lb 9/21/2007 Other Health Professional United States
Primary
Secondary
Concomitant
Tonsillectomy Other Serious 1/1/1992 67 Female 112 lb 11/15/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 4/13/1998 52 Female 225 lb 9/17/2007 Lawyer United States
Primary
Secondary
Concomitant
Unevaluable Event Other Serious 1/1/1992 67 Female 112 lb 9/17/2007 Lawyer United States
Primary
Secondary
Concomitant
Metrorrhagia Other Serious 12/1/1994 55 Female 9/17/2007 Lawyer United States
Primary
Secondary
Concomitant
Rectal Polypectomy Other Serious 1/1/1997 53 Female 105 lb 12/4/2007 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 12/27/2001 57 Female 139 lb 1/10/2008 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/20/2004 58 Female 122 lb 12/18/2007 United States
Primary
Secondary
Spinal Cord Disorder Other Serious 1/1/1997 53 Female 105 lb 3/27/2008 United States
Primary
Secondary
Concomitant
Pre-eclampsia Other Serious 37 Female 4/3/2008 Other Health Professional United States
Primary
Concomitant
Intra-uterine Death Other Serious 10/17/2007 37 Female 4/3/2008 Other Health Professional United States
Primary
Concomitant
Ovarian Cancer Metastatic Other Serious 8/1/2002 59 Female 163 lb 7/20/2006 Lawyer United States
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 5/25/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 10/1/2000 59 Female 157 lb 2/5/2007 Lawyer United States
Primary
Secondary
Fibrocystic Breast Disease Other Serious 8/1/2004 53 Female 126 lb 5/11/2007 Physician United States
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 1/1/1994 56 Female 157 lb 4/8/2008 United States
Primary
Secondary
Concomitant
Contralateral Breast Cancer Other Serious 2/22/2002 Female 5/1/2008 Consumer United States
Primary
Secondary
White Blood Cell Count Decreased Other Serious 1/1/1994 Female 157 lb 6/19/2008 United States
Primary
Secondary
Concomitant
Ovarian Cancer Other Serious 1/1/2003 Female 161 lb 6/27/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Female 7/16/2008 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 7/16/2008 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2002 69 Female 128 lb 8/18/2008 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2003 67 Female 104 lb 8/19/2008 Lawyer United States
Primary
Secondary
Contralateral Breast Cancer Other Serious 2/22/2002 Female 8/25/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2003 Female 8/29/2008 Lawyer United States
Primary
Secondary
Splenic Artery Aneurysm Other Serious 5/2/2008 63 Female 154 lb 10/13/2008 Consumer United States
Primary
Concomitant
Cerebrovascular Accident Other Serious 1/1/2003 59 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/25/2002 57 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1999 64 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 3/15/1996 36 Female 10/9/2008 Lawyer United States
Primary
Secondary
Ovarian Cancer Metastatic Other Serious 8/1/2002 59 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2001 51 Female 140 lb 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 10/31/2000 65 Female 140 lb 10/9/2008 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 8/31/2004 53 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2003 67 Female 104 lb 12/19/2008 Lawyer United States
Primary
Secondary
Laboratory Test Abnormal Other Serious 5/29/2003 Female 12/23/2008 Other Health Professional United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2003 Female 1/8/2009 Lawyer United States
Primary
Secondary
Splenic Artery Aneurysm Other Serious 5/2/2008 63 Female 154 lb 1/12/2009 Consumer United States
Primary
Concomitant
Injury Other Serious Female 1/17/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 4/10/1997 53 Female 12/19/2008 United States
Primary
Secondary

Drug Data